LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 feb. 2026, 23:53 UTC

Acțiuni populare

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 feb. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28 feb. 2026, 21:36 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 15:20 UTC

Câștiguri

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 feb. 2026, 14:43 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 14:38 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 feb. 2026, 13:47 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 13:44 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 feb. 2026, 13:14 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 02:32 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 feb. 2026, 02:00 UTC

Achiziții, Fuziuni, Preluări

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 feb. 2026, 02:00 UTC

Achiziții, Fuziuni, Preluări

Six Months, 9 Offers and $81 Billion. How -2-

28 feb. 2026, 00:01 UTC

Achiziții, Fuziuni, Preluări

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 feb. 2026, 23:46 UTC

Achiziții, Fuziuni, Preluări

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 feb. 2026, 23:33 UTC

Achiziții, Fuziuni, Preluări

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

27 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 feb. 2026, 21:30 UTC

Câștiguri

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 feb. 2026, 21:30 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 feb. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 feb. 2026, 21:17 UTC

Câștiguri

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 feb. 2026, 21:10 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 feb. 2026, 21:09 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 feb. 2026, 21:00 UTC

Câștiguri

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 feb. 2026, 20:31 UTC

Achiziții, Fuziuni, Preluări

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 feb. 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 feb. 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 feb. 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27 feb. 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27 feb. 2026, 19:39 UTC

Câștiguri

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat